Atezolizumab in Metastatic Urothelial Carcinoma Outside Clinical Trials: Focus on Efficacy, Safety, and Response to Subsequent Therapies

被引：0
|
作者：
Pedro C. Barata
Dhrmesh Gopalakrishnan
Vadim S. Koshkin
Prateek Mendiratta
Matt Karafa
Kimberly Allman
Allison Martin
Jennifer Beach
Pam Profusek
Allison Tyler
Laura Wood
Moshe Ornstein
Timothy Gilligan
Brian I. Rini
Jorge A. Garcia
Petros Grivas
机构：
[1] Taussig Cancer Institute Cleveland Clinic,Department of Hematology & Medical Oncology
[2] Cleveland Clinic,Department of Hospital Medicine
[3] Cleveland Clinic,Quantitative Health Sciences
[4] University of Washington and Fred Hutchinson Cancer Research Center,Department of Medicine, Division of Oncology
[5] Seattle Cancer Care Alliance,undefined
来源：
Targeted Oncology | 2018年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：353 / 361
页数：8
相关论文
共 50 条
  • [31] The efficacy and safety of immunotherapy targeting the PD-1 pathway for advanced urothelial carcinoma: a meta-analysis of published clinical trials
    Zhang, F.
    Liu, Z.
    Liang, J.
    Wu, K.
    Zhou, C.
    Lu, Y.
    Wang, X.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (10): : 1750 - 1761
  • [32] The efficacy and safety of immunotherapy targeting the PD-1 pathway for advanced urothelial carcinoma: a meta-analysis of published clinical trials
    F. Zhang
    Z. Liu
    J. Liang
    F. Zhang
    K. Wu
    C. Zhou
    Y. Lu
    X. Wang
    Clinical and Translational Oncology, 2020, 22 : 1750 - 1761
  • [33] The safety and efficacy of rituximab in patients with rheumatoid arthritis outside clinical trials: real life experience
    Dass, S.
    Vital, E. M.
    Bingham, S. J.
    Emery, P.
    RHEUMATOLOGY, 2006, 45 : I47 - I47
  • [34] Case Report: Safety and Efficacy of Enfortumab Vedotin in a Patient With Metastatic Urothelial Carcinoma Undergoing Peritoneal Dialysis
    Collette, Kaylyn R.
    Myint, Zin W.
    Parasramka, Saurabh V.
    Ellis, Carleton S.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Progression-free survival is an adequate endpoint for clinical trials of locally advanced and metastatic urothelial carcinoma
    Martini, Alberto
    Fallara, Giuseppe
    Ploussard, Guillaume
    Pradere, Benjamin
    CURRENT OPINION IN UROLOGY, 2022, 32 (05) : 500 - 503
  • [36] Treatment with Atezolizumab-Bevacizumab for hepatocellular carcinoma in the french population outside clinical trials: data from the prospective CHIEF cohort
    Allaire, Manon
    Hajer, Ben Khadhra
    Amaddeo, Giuliana
    Bouattour, Mohamed
    Brusset, Bleuenn
    Ziol, Marianne
    Merle, Philippe
    Blanc, Jean-Frederic
    Uguen, Thomas
    Ganne-Carrie, Nathalie
    Cattan, Stephane
    Riachi, Ghassan
    Loustaud-Ratti, Veronique
    Decaens, Thomas
    Silvain, Christine
    Peron, Jean Marie
    Baron, Aurore
    Pageaux, Georges-Philippe
    Oberti, Frederic
    Anty, Rodolphe
    Manfredi, Sylvain
    Bourliere, Marc
    Ben Merabet, Yasmina
    Nousbaum, JeanB-aptiste
    Heurgue-Berlot, Alexandra
    Ollivier-Hourmand, Isabelle
    Ducournau, Gerard
    Ganry, Olivier
    Costentin, Charlotte
    Khac, Eric Nguyen
    JOURNAL OF HEPATOLOGY, 2024, 80 : S444 - S444
  • [37] Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial
    Powles, Thomas
    Atkins, Michael B.
    Escudier, Bernard
    Motzer, Robert J.
    Rini, Brian, I
    Fong, Lawrence
    Joseph, Richard W.
    Pal, Sumanta K.
    Sznol, Mario
    Hainsworth, John
    Stadler, Walter M.
    Hutson, Thomas E.
    Ravaud, Alain
    Bracarda, Sergio
    Suarez, Cristina
    Choueiri, Toni K.
    Reeves, James
    Cohn, Allen
    Ding, Beiying
    Leng, Ning
    Hashimoto, Kenji
    Huseni, Mahrukh
    Schiff, Christina
    McDermott, David F.
    EUROPEAN UROLOGY, 2021, 79 (05) : 665 - 673
  • [38] Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials
    Lakshman, Arjun
    Abeykoon, Jithma P.
    Kumar, Shaji K.
    Rajkumar, S. Vincent
    Dingli, David
    Buadi, Francis K.
    Gonsalves, Wilson I.
    Leung, Nelson
    Dispenzieri, Angela
    Kourelis, Taxiarchis V.
    Go, Ronald S.
    Lacy, Martha Q.
    Hobbs, Miriam A.
    Lin, Yi
    Warsame, Rahma
    Lust, John
    Fonder, Amie L.
    Hwa, Yi L.
    Hayman, Suzanne R.
    Russell, Stephen J.
    Kyle, Robert A.
    Gertz, Morie A.
    Kapoor, Prashant
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (11) : 1146 - 1155
  • [39] Efficacy and Safety of Bevacizumab and Chemotherapy in Combination with Atezolizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials
    Jiang, Chenfei
    Chen, Dong
    Sun, Bin
    Wang, Rujia
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (09): : 4547 - 4554
  • [40] Patients (Pts) with Metastatic Renal Cell Carcinoma (mRCC) Receiving Angiogenesis Inhibitor (AI) Therapies: Treatment Efficacy and Safety in Clinical Practice
    McDermott, David
    Choueiri, Toni K.
    Clement, Jessica
    Brick, Ashley J.
    Kwabi, Christabel
    Shah, Karishma
    Antras, Lucia
    Jayawant, Sujata S.
    Wang, Si-Tien
    Luka, Andi
    Duh, Mei Sheng
    Neary, Maureen
    Oh, William K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S111 - S112
12345